US FDA panel recommends Vertex cystic fibrosis Orkambi treatment

WASHINGTON, May 12 (Reuters) - A Food and Drug Administration advisory committee recommended approval of Vertex Pharmaceutical Inc's Orkambi treatment for cystic fibrosis, finding the combination therapy safe and effective for patients aged 12 and up. (Reporting by David Morgan; Editing by Diane Craft)